Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.44
Delayed Data
As of 11:20am ET
 -0.08 / -1.45%
Today’s Change
3.42
Today|||52-Week Range
6.62
+29.52%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.52
Today’s open5.52
Day’s range5.44 - 5.53
Volume98,475
Average volume (3 months)888,559
Market cap$463.2M
Data as of 11:20am ET, 09/18/2019

Growth & Valuation

Earnings growth (last year)-18.99%
Earnings growth (this year)-7.76%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+33.54%
P/E ratioNM
Price/Sales20.94
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.26-3.00%
EOLSEvolus Inc-0.25-1.46%
KNSAKiniksa Pharmaceutic...+0.06+0.68%
APMAptorum Group Ltd+0.02+0.09%
Data as of 11:35am ET, 09/18/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$15.6M
Annual profit (last year)-$67.7M
Net profit margin-433.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Secretary &
Senior VP
Patrick Fabbio
Corporate headquarters
New York, New York

Forecasts